Evidence map›Paper›PMID 10359583›Full record

ArticleThe Journal of experimental medicine1999

Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses.

C López-Macías, U Kalinke, M Cascalho, M Wabl, H Hengartner, R M Zinkernagel, A Lamarre

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Neutralizing antiviral antibody responses.Advances in immunology · 2001
    Review
  9. Review
  10. Article
  11. Germinal centers without T cells.The Journal of experimental medicine · 2000
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

C López-MacíasInstitute of Experimental Immunology, Department of Pathology, University Hospital, CH-8091 Zürich, Switzerland.
U Kalinke
M Cascalho
M Wabl
H Hengartner
R M Zinkernagel
A Lamarre

Funding

GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEMR01AI041570 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WABL, MATTHIAS R · 1998 to 2014
$4.6M
NIAID NIH HHS R01 AI041570NIAID NIH HHS R01 AI41570
6 · The paper itself

Abstract

Variable (V) region gene replacement was recently implicated in B cell repertoire diversification, but the contribution of this mechanism to antibody responses is still unknown. To investigate the role of V gene replacements in the generation of antigen-specific antibodies, we analyzed antiviral immunoglobulin responses of "quasimonoclonal" (QM) mice. The B cells of QM mice are genetically committed to exclusively express the anti-(4-hydroxy-3-nitrophenyl) acetyl specificity. However, approximately 20% of the peripheral B cells of QM mice undergo secondary rearrangements and thereby potentially acquire new specificities. QM mice infected with vesicular stomatitis virus (VSV), lymphocytic choriomeningitis virus, or poliovirus mounted virus-specific neutralizing antibody responses. In general, kinetics of the antiviral immunoglobulin responses were delayed in QM mice; however, titers similar to control animals were eventually produced that were sufficient to protect against VSV-induced lethal disease. VSV neutralizing single-chain Fv fragments isolated from phage display libraries constructed from QM mice showed VH gene replacements and extensive hypermutation. Thus, our data demonstrate that secondary rearrangements and hypermutation can generate sufficient B cell diversity in QM mice to mount protective antiviral antibody responses, suggesting that these mechanisms might also contribute to the diversification of the B cell repertoire of normal mice.

Indexed as

Antibody DiversityGene Rearrangement, B-LymphocyteMutationAnimalsAntibodies, ViralBase SequenceB-LymphocytesDNAGene TargetingMiceMice, Inbred C57BLNeutralization TestsSequence Homology, Nucleic AcidVesicular stomatitis Indiana virusAntibodies, ViralDNA

Identifiers

PMID10359583
PMCPMC2193076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.